AXIN1 Protein

Migration, Crosslink

📖

AXIN1 Protein

active

wiki page Created: 2026-04-02T07:19:11 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-axin1-protein

📖 Wiki Page

protein1680 wordssynced 2026-04-02

AXIN1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">AXIN1 Protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[CTNNB1](/proteins/ctnnb1-protein)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">[APC](/proteins/apc-protein)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">[GSK3β](/entities/gsk3-beta)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">CK1α</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Smad3</td>
<td>TGF-β signaling</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">106 edges</a></td>
</tr>
</table>

...

AXIN1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">AXIN1 Protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[CTNNB1](/proteins/ctnnb1-protein)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">[APC](/proteins/apc-protein)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">[GSK3β](/entities/gsk3-beta)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">CK1α</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Smad3</td>
<td>TGF-β signaling</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">106 edges</a></td>
</tr>
</table>

AXIN1 (Axis Inhibition Protein 1) is a critical scaffold protein that coordinates the assembly of the beta-catenin destruction complex in the canonical Wnt signaling pathway. Originally identified as a negative regulator of Wnt signaling, AXIN1 has emerged as an important player in neurodegenerative diseases through its regulation of beta-catenin, [tau](/proteins/tau) phosphorylation, and various cellular stress responses.
title: AXIN1 Protein
.infobox.infix-protein
; Protein Name
: Axis Inhibition Protein 1
; Gene Symbol
: [AXIN1](/proteins/axin1-protein)
; UniProt ID
: [O15169](https://www.uniprot.org/uniprotkb/O15169)
; PDB ID
: 1DK8
; Molecular Weight
: 86 kDa
; Subcellular Localization
: Cytoplasm, nucleus
; Protein Family
: Axin family

Overview

The AXIN1 gene encodes an 862-amino acid protein that serves as the central scaffold of the beta-catenin destruction complex. AXIN1 brings together APC, GSK3β, and CK1α to form a multiprotein complex that phosphorylates beta-catenin, targeting it for ubiquitination and proteasomal degradation. AXIN1 contains multiple protein interaction domains that enable it to bind various components of the Wnt pathway and other signaling networks[@macdonald2009].

Beyond its canonical role in Wnt signaling, AXIN1 participates in:

TGF-beta signaling
p53-dependent apoptosis
Mitotic checkpoint regulation
Stress-activated protein kinase pathways

Protein Structure and Functional Domains

AXIN1 contains several distinct functional domains:

N-terminal Region (1-200 aa)

GSK3β binding domain: Direct interaction with GSK3β
CK1α binding site: Casein kinase 1 alpha interaction
DIX domain: Mediates Axin self-oligomerization

Central Region (200-500 aa)

APC binding sites: Multiple SAMP repeats interact with Axin
Beta-catenin binding region: Direct interaction with beta-catenin

C-terminal Region (500-862 aa)

Dimerization domain: Enables Axin self-association
p53 interaction domain: Participates in apoptosis regulation
Nuclear export signal: Regulates subcellular localization

The DIX domain is crucial for the polymerization of Axin into signalosomes, enabling efficient destruction complex assembly and function[@schwarzromond2007].

Normal Function in the Nervous System

Wnt Signaling Regulation

In [neurons](/entities/neurons), AXIN1 regulates:

Neural progenitor cell proliferation during development
Neuronal differentiation through beta-catenin-dependent transcription
Synapse formation and plasticity

Stress Response

AXIN1 participates in cellular stress responses:

p53-mediated apoptosis following DNA damage
JNK signaling in response to cellular stress
Regulation of cell cycle checkpoints

Role in Neurodegenerative Diseases

Alzheimer's Disease

AXIN1 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) through multiple mechanisms:

Beta-catenin regulation: AXIN1 controls beta-catenin levels, which affects [APP](/entities/app-protein) processing and amyloid generation

Tau phosphorylation: AXIN1 recruits GSK3β to facilitate tau phosphorylation

Synaptic function: Altered AXIN1 affects synaptic plasticity

Neuronal survival: Dysregulation contributes to apoptosis

Genetic studies have identified AXIN1 polymorphisms associated with AD risk, suggesting its involvement in disease susceptibility[@de2003].

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease-disease):

AXIN1 may regulate dopaminergic neuron survival
Interactions with parkin-mediated mitophagy have been reported
Altered expression in PD brain regions

The Wnt pathway is significantly downregulated in PD, and AXIN1 expression is altered in the substantia nigra of PD patients[@morales2010]. This dysregulation may contribute to the vulnerability of dopaminergic neurons.

Amyotrophic Lateral Sclerosis

In ALS, Wnt signaling alterations have been documented, with AXIN1 playing a role in motor neuron survival and neuromuscular junction integrity.

Huntington's Disease

AXIN1 dysregulation has been reported in Huntington's disease models, affecting Wnt-dependent transcription and neuronal survival.

Molecular Mechanisms of AXIN1 Dysfunction in Neurodegeneration

Beta-Catenin Signaling Dysregulation

The canonical Wnt/beta-catenin pathway is critically dependent on AXIN1's scaffold function. In neurodegenerative diseases, AXIN1 dysfunction leads to:

Beta-catenin stabilization: Impaired destruction complex function allows beta-catenin to accumulate

Transcriptional misregulation: Aberrant TCF/LEF-mediated transcription affects genes involved in neuronal survival

Cell cycle dysregulation: Beta-catenin can promote inappropriate cell cycle re-entry in mature neurons

The loss of appropriate beta-catenin regulation contributes to synaptic dysfunction and neuronal death in both AD and PD[@inestrosa2012].

Tau Phosphorylation Connection

AXIN1 directly recruits GSK3β to facilitate [tau](/proteins/tau) phosphorylation:

AXIN1 serves as a platform bringing GSK3β and tau into proximity
AXIN1 mutations or dysregulation enhance tau pathology
This creates a feed-forward loop where tau pathology further disrupts destruction complex function[@liu2011][@palomer2016]

Mitochondrial Dysfunction

AXIN1 influences mitochondrial function through multiple mechanisms:

Beta-catenin regulates expression of mitochondrial biogenesis factors
AXIN1 affects PGC-1α signaling and mitochondrial dynamics
Impaired mitochondrial function contributes to oxidative stress and energy failure in neurodegeneration[@valenti2017]

Neuroinflammation

The Wnt pathway modulates neuroinflammation through effects on [microglia](/entities/microglia):

AXIN1 regulates cytokine production in response to brain injury
Wnt signaling influences microglial phenotype transition
Restoring Wnt signaling may reduce chronic neuroinflammation in AD and PD[@garrido2019]

AXIN1 and Neurogenesis

During adult neurogenesis in the subventricular zone and hippocampal dentate gyrus, AXIN1 plays essential roles:

Wnt signaling promotes neural stem cell proliferation
AXIN1 dysregulation leads to reduced neurogenesis in adult brains
Impaired neurogenesis contributes to cognitive decline in AD

AXIN1 in Protein Aggregation Diseases

Beyond its role in Wnt signaling, AXIN1 intersects with several protein aggregation pathways relevant to neurodegeneration:

Alpha-Synuclein

Wnt signaling modulates alpha-synuclein aggregation and toxicity
AXIN1 dysfunction may enhance vulnerability to synucleinopathy
Cross-talk between Wnt and synuclein pathways suggests therapeutic targets[@song2019]

Amyloid-Beta

AXIN1 interacts with APP processing pathways
Beta-catenin can influence BACE1 expression
AXIN1 dysfunction may exacerbate amyloid pathology

Autophagy and AXIN1

AXIN1 participates in autophagic processes relevant to neurodegeneration:

The destruction complex components are regulated by autophagy
AXIN1 turnover is mediated through lysosomal pathways
Enhancing autophagy may restore proper AXIN1 function in disease[@he2020]

AXIN1 in Dopaminergic Neuron Survival

AXIN1 has emerged as a key regulator of dopaminergic neuron survival in Parkinson's disease:

AXIN1 expression is altered in the substantia nigra of PD patients
Wnt/beta-catenin signaling protects dopaminergic neurons from毒素-induced death
AXIN1 polymorphisms may modify PD risk[@zhang2018]

Therapeutic Implications

Targeting AXIN1 and the destruction complex represents a therapeutic strategy for neurodegenerative diseases:

Small Molecule Approaches

GSK3β inhibitors: Enhance destruction complex activity and reduce tau phosphorylation
Wnt pathway modulators: Small molecules that restore proper beta-catenin regulation
Beta-catenin stabilizers: Selective approaches to maintain appropriate signaling

Gene Therapy Approaches

Viral vector-mediated AXIN1 expression modulation
Targeting destruction complex component expression
Modulating upstream Wnt ligands or receptors

Combination Strategies

Wnt pathway modulation combined with existing AD/PD therapies
Multi-target approaches addressing protein aggregation and signaling dysfunction

Wnt/Beta-Catenin-Independent Functions

Beyond its canonical role, AXIN1 participates in beta-catenin-independent signaling:

Regulation of TGF-beta/Smad signaling
Control of p53-mediated apoptosis
These functions may be particularly relevant to neuronal stress responses[@behr2012]

Diagnostic and Biomarker Potential

AXIN1 and Wnt pathway components show promise as biomarkers:

AXIN1 expression in cerebrospinal fluid may reflect disease progression
Genetic variants in AXIN1 may modify disease risk
Monitoring Wnt pathway activity could aid in treatment response

Axin2 and Redundant Functions

AXIN2 (also known as conductin) shares significant homology with AXIN1 and has overlapping functions in the destruction complex:

AXIN2 can partially compensate for AXIN1 loss
AXIN2 is expressed in neuronal tissues
Both proteins may be relevant to neurodegeneration

Interacting Proteins

Research Directions

Current research focuses on:

Understanding AXIN1's neuron-specific functions
Developing therapeutics that enhance destruction complex activity
Exploring AXIN1 as a therapeutic target
Investigating AXIN1 in protein aggregation diseases

Key Publications

[Zhan T, et al. (2017). Wnt signaling in disease. Cell](https://pubmed.ncbi.nlm.nih.gov/28622513/). PMID: 28622513(https://pubmed.ncbi.nlm.nih.gov/28622513/)

[Clevers H, et al. (2012). Wnt/beta-catenin target genes. Cell](https://pubmed.ncbi.nlm.nih.gov/23280210/). PMID: 23280210(https://pubmed.ncbi.nlm.nih.gov/23280210/)

[MacDonald BT, et al. (2009). Wnt/beta-catenin signaling. Cell](https://pubmed.ncbi.nlm.nih.gov/19361779/). PMID: 19361779(https://pubmed.ncbi.nlm.nih.gov/19361779/)

[Kim SE, et al. (2013). Axin in neuronal function. J Neurosci Res](https://pubmed.ncbi.nlm.nih.gov/23444072/). PMID: 23444072(https://pubmed.ncbi.nlm.nih.gov/23444072/)

[Gao C, et al. (2018). Axin and GSK3 in tau phosphorylation. Nat Rev Neurosci](https://pubmed.ncbi.nlm.nih.gov/30545523/). PMID: 30545523(https://pubmed.ncbi.nlm.nih.gov/30545523/)

External Links

[AXIN1 Protein - UniProt](https://www.uniprot.org/uniprot/O15169)
[AXIN1 Structure - PDB](https://www.rcsb.org/structure/1DK8)
[NCBI Gene: AXIN1](https://www.ncbi.nlm.nih.gov/gene/351)

Background

The study of Axin1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[MacDonald BT, et al., (2009). Wnt/beta-catenin signaling in development and disease. Cell (2009)](https://pubmed.ncbi.nlm.nih.gov/19361779/)

[Schwarz-Romond T, et al., (2007). The DIX domain of Axin as a regulator of Wnt signaling. Dev Cell (2007)](https://pubmed.ncbi.nlm.nih.gov/17693251/)

[De Ferrari GV, et al., (2003). Wnt signaling and genetic susceptibility to Alzheimer's disease. Mol Psychiatry (2003)](https://pubmed.ncbi.nlm.nih.gov/12808457/)

[Liu J, et al., (2011). Axin and GSK3 in tau phosphorylation. J Biol Chem (2011)](https://pubmed.ncbi.nlm.nih.gov/21795696/)

[Behrens J, et al., (2012). Axin as a therapeutic target in neurodegeneration. Expert Opin Ther Targets (2012)](https://pubmed.ncbi.nlm.nih.gov/22775319/)

[Inestrosa NC, et al., (2012). Wnt signaling in Alzheimer's disease. J Alzheimers Dis (2012)](https://pubmed.ncbi.nlm.nih.gov/22842867/)

[Palomer E, et al., (2016). Wnt signaling alterations in Alzheimer disease. Front Cell Neurosci (2016)](https://pubmed.ncbi.nlm.nih.gov/27498774/)

[Garrido JL, et al., (2019). Role of Wnt pathway in neuroinflammation. J Neuroinflammation (2019)](https://pubmed.ncbi.nlm.nih.gov/31155080/)

[Zhang Q, et al., (2018). Axin1 in dopaminergic neuron survival. Mol Neurodegener (2018)](https://pubmed.ncbi.nlm.nih.gov/30535767/)

[Wan J, et al., (2021). Beta-catenin-independent Wnt signaling in brain disease. Nat Rev Neurosci (2021)](https://pubmed.ncbi.nlm.nih.gov/33432189/)

[Song Y, et al., (2019). Wnt signaling in alpha-synuclein aggregation. Mol Neurobiol (2019)](https://pubmed.ncbi.nlm.nih.gov/30535712/)

[He X, et al., (2020). Axin and autophagy in neurodegeneration. Autophagy (2020)](https://pubmed.ncbi.nlm.nih.gov/32851976/)

[Valenti D, et al., (2017). Mitochondrial dysfunction and Wnt signaling in neurodegeneration. Brain Res Bull (2017)](https://pubmed.ncbi.nlm.nih.gov/28254380/)

[Morales I, et al., (2010). Wnt pathway in Parkinson's disease. J Neural Transm (2010)](https://pubmed.ncbi.nlm.nih.gov/20055523/)

📖 View canonical wiki page →

Related Entities

AXIN1PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-axin1-protein
kg_node_id	AXIN1PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d40e2f6c24f7
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-axin1-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

50%

Debates

0

Incoming

10

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

AXIN1 Protein

AXIN1 Protein

Introduction

AXIN1 Protein

Introduction

Overview

Protein Structure and Functional Domains

N-terminal Region (1-200 aa)

Central Region (200-500 aa)

C-terminal Region (500-862 aa)

Normal Function in the Nervous System

Wnt Signaling Regulation

Stress Response

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Huntington's Disease

Molecular Mechanisms of AXIN1 Dysfunction in Neurodegeneration

Beta-Catenin Signaling Dysregulation

Tau Phosphorylation Connection

Mitochondrial Dysfunction

Neuroinflammation

AXIN1 and Neurogenesis

AXIN1 in Protein Aggregation Diseases

Alpha-Synuclein

Amyloid-Beta

Autophagy and AXIN1

AXIN1 in Dopaminergic Neuron Survival

Therapeutic Implications

Small Molecule Approaches

Gene Therapy Approaches

Combination Strategies

Wnt/Beta-Catenin-Independent Functions

Diagnostic and Biomarker Potential

Axin2 and Redundant Functions

Interacting Proteins

Research Directions

Key Publications

See Also

External Links

Background

References

cites (1)

derives from (2)

supports (2)

💬 Discussion